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Abstract
Purpose—To investigate whether oxygen stresses experienced in retinopathy of prematurity
(ROP) would trigger signaling through reactive oxygen species (ROS) and the Janus kinase-signal
transducer and activator of transcription (JAK/STAT) pathways to lead to intravitreous
neovascularization (IVNV) in an oxygen-induced retinopathy (OIR) rat model.
Methods—Newborn rat pups exposed to repeated fluctuations in oxygen and rescued in
supplemental oxygen (28% O2, 50/10 OIR+SO) were treated with apocynin, an NADPH oxidase
and ROS inhibitor (10 mg/kg/day), AG490, a JAK2 inhibitor (5mg/kg/day), or phosphate buffered
saline (PBS). Intraperitoneal injections were given from postnatal day (p)12-p17 (apocynin), or
from p3-p17 (AG490). Outcomes were intravitreous neovascularization and avascular/total retinal
areas, vascular endothelial growth factor (VEGF), phosphorylated JAK2, and phosphorylated
STAT3.
Results—Apocynin significantly reduced phosphorylated STAT3 in 50/10 OIR+SO (p=0.04), in
association with previously reported inhibition of IVNV area. Inhibition of JAK with AG490
significantly reduced phosphorylated JAK2 (p<0.001), phosphorylated STAT3 (p=0.002), and
IVNV area (p=0.033) in the 50/10 OIR+SO model compared to control.
Conclusions—Activation of NADPH oxidase from supplemental oxygen works via activated
STAT3 to lead to IVNV. In addition, inhibition of the JAK/STAT pathway reduces IVNV. Further
studies are needed to determine the effects and relationships of oxygen stresses on JAK/STAT and
NAPDH oxidase signaling.
INTRODUCTION
Retinopathy of prematurity (ROP) is a leading cause of nonreversible childhood blindness
world wide. When first described in the 1940’s and 50’s1, ROP likely developed as a result
of unregulated high inspired oxygen at birth. Now both inspired oxygen and infant oxygen
saturation are monitored, and high oxygen at birth2,3 rarely occurs in preterm infants in the
US. However, fluctuations in oxygen and supplemental inspired oxygen later in the course
of prematurity have been reported as associated with increased risk of developing severe
ROP as it is known today4,5,6,7,8.
In a model of ROP that treats newborn rat pups to repeated fluctuations in oxygen, we found
that reactive oxygen species (ROS) were increased in the retina and that NADPH oxidase
was activated to trigger apoptosis of endothelial cells, which contributed to avascular
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retina9. When pups subjected to oxygen fluctuations were placed into supplemental oxygen
instead of room air, there was exacerbation of NADPH oxidase activation that contributed to
angiogenic blood vessel growth into the vitreous10. This intravitreous neovascularization
(IVNV) appeared, in part, to be independent of vascular endothelial growth factor
(VEGF)10.
The Janus kinase-signal transducer and activator of transcription (JAK/STAT) signaling
pathway can lead to angiogenesis through ROS either by triggering angiogenic factors, such
as VEGF11,12, or through alternate pathways13,14. We wished to determine the role of JAK/
STAT signaling in IVNV and used models of ROP that expose pups to oxygen stresses
similar to those experienced by preterm infants at risk for severe ROP as it is known today
(i.e., repeated fluctuations in oxygen and supplemental oxygen). Our hypothesis is that
oxygen stresses experienced by preterm infants trigger signaling through JAK/STAT
pathways to contribute to IVNV. To address this, we used a JAK2 inhibitor [AG490
(tyrphostin)], which is a chemical compound that potently inhibits JAK2 protein tyrosine
kinase (PTK) and blocks the constitutive activation of STAT3 to inhibit DNA synthesis and
cell growth, and induce apoptosis15. We measured IVNV area and avascular retina in our
models. Since NADPH oxidase can also increase IVNV when supplemental oxygen was an
added stress, we studied its potential role in JAK/STAT signaling of angiogenesis.
MATERIALS AND METHODS
All animals were cared for in accordance with the University of North Carolina’s Institute
for Laboratory Animal Research (Guide for the Care and Use of Laboratory Animals) and
the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
50/10 Oxygen-Induced Fluctuations and Supplemental Oxygen Rat Model
A bioactive gas controller (Oxycycler; BioSpherix, New York, NY), which regulates the
atmosphere inside an incubator by injecting either nitrogen or oxygen, was used to induce
oxygen-induced retinopathy in newborn Sprague-Dawley rats (Charles River, Wilmington,
MA), as previously reported16. Within 4 hours of birth, pups and their mothers were placed
into the incubator, which cycled oxygen between 50% and 10% every 24 hours for 14 days.
Thereafter, pups were placed in supplemental oxygen (28% O2) for 4 days (50/10 OIR+SO).
Carbon dioxide in the chambers was monitored and flushed from the system by maintaining
sufficient gas flow and using soda lime. Litter numbers were between 12 and 14 pups for
each experiment to assure consistency in outcomes and all animals were weighed and mean
body weight of litters found to be within ± 2 g of each other at the time of treatment.
Treatment with AG490 and Apocynin
AG490 (LC Laboratories, Woburn, MA) is a synthetic PTK inhibitor that inhibits JAK217
and JAK3 activation. It selectively blocks cell survival and proliferation by inducing
programmed cell death and was used to inhibit the JAK/STAT pathway in rats18. To test
whether JAK2 inhibition affects signaling through STAT to cause apoptosis or angiogenesis
and ultimately lead to IVNV in the 50/10 OIR model, we treated rat pups with 5mg/kg
AG490 5% dimethyl sulfoxide (DMSO, MP Biomedicals, Solon, OH) in phosphate buffered
saline (PBS, Sigma, St. Louis, MI). Intraperitoneal (IP) injections (5μL/g body weight) were
administered daily from p3 to p6, p3 to p13, or p3 to p17. Control animals received IP
injections of sterile 5% DMSO in PBS. Separate litters received IP injections of apocynin
(4-acetovanillione, Sigma, St. Louis, MI) in sterile PBS at 10 mg/kg, (5μl/g body weight)
once a day from p12 to p17, as previously reported10. Controls received IP injections of
sterile PBS at 5μl/g. Pups were removed from cycling for less than 20 minutes for
treatments.
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Rat pups were anesthetized by IP injection of ketamine (60 mg/kg) and xylazine (18 mg/kg)
then perfused with intracardiac paraformaldehyde (PFA, 1.0 mL, 0.5%) prior to euthanasia
by intracardiac pentobarbital (50ul, 80mg/kg). Eyes were enucleated and prefixed in 2%
PFA for 2 hrs before anterior segments, hyaloidal vessels and vitreous were removed.
Retinas with intact ora serratas were dissected, placed into PBS, and flattened onto
microscope slides by making 4 right angle incisions. For fresh tissue, animals were
euthanized with pentobarbital (80 mg/kg IP), and retinas were isolated without ora serratas.
Tissue was frozen in RIPA buffer with protease cocktail inhibitor (1:100, Sigma, St. Louis,
MI) and orthovanadate (1mM, Sigma) for protein or RNAlater (Ambion, Austin, TX) for
RNA and stored at −80°C until analysis.
Staining Retinal Flat mounts
Flattened retinas were permeabilized in ice cold ethanol (70% v/v) for 20 minutes then in
PBS/1% Triton x-100 for 30 minutes. Retinas were incubated with Alexa Fluor 568
conjugated Griffonia simplicifolia (Bandeiraea) isolectin B4 (5 μg/ml, Molecular Probes,
OR) in PBS overnight at 4°C, then rinsed three times in PBS and mounted in PBS:glycerol
(2:1) with VectaShield (Vector Labs, CA). Slides were secured with coverslips and sealed
with nail varnish. Images of the retinal blood vessels were captured using a Nikon TE2000U
inverted microscope (Michael-Hooker Microscopy Facility, University of North Carolina,
Chapel Hill, NC) and digitally stored for analysis.
Measurement of IVNV and Avascular Areas
To measure IVNV, digitized retinal image sections were assembled with methods that
maintain original image dimensions (Tekmate’s PhotoFit Premium v1.44, Tekmate Inc.,
AK). Total retinal area, summed peripheral avascular retinal and IVNV areas19 were
computed in pixels with Image Tool v.3 (University of Texas, San Antonio, TX) and
converted to mm2 (using a calibration bar on each image). IVNV has been defined as
neovascularization growing into the vitreous at the junction of vascular and avascular
retina20. Avascular areas were expressed as a percent of total retinal area for each eye.
Measurements were performed by two independent masked reviewers. A third reviewer was
used to rectify discrepancies in measurements and a final consensus determined.
REAL-TIME PCR
Samples were removed from RNAlater and total RNA was extracted using the RNeasy Mini
kit (Qiagen, Valencia, CA). DNA contamination was removed by using DNA-free (Ambion,
Austin, TX), and RNA quantity was determined spectrophotometrically. 1 μg of RNA from
each sample was reverse transcribed the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Foster City, CA). Approximately 200 ng of cDNA were analyzed per
well by one step real time PCR using the TaqMan MasterMix with reverse transcriptase (3.7
U/reaction, Applied Biosystems, Foster City, CA) and primers specific to rat STAT3
(forward CTAGACAATATCATCATCGACCTTG; reverse
TCCCGCTCCTTGCTGATGA, annealing temperature 60°C). Rat β-actin was used as the
control gene and was amplified with forward and reverse primers
TGCCTGACGGTCAGGTCA and CAGGAAGGAAGGCTGGAAG, respectively.
Duplicate reactions in addition to controls were run for each sample in a total volume of 16
μL. Cycle threshold (CT) values were normalized to β-actin and expressed as a fold increase
over mRNA expressed at birth (post-natal day 0).
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Protein Extraction, Western Blotting
Retinal samples frozen in modified radio immuno precipitation assay (RIPA) buffer (20 mM
Tris base, 120 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 10%
glycerol) with protease cocktail inhibitor (1:100, Sigma, St. Louis, MI) and orthovanadate
(1mM, Sigma, St. Louis, MI) were homogenized and centrifuged at 13,000 rpm for 10
minutes at 4°C. Total protein in the supernatant was quantified by Bicinchoninic Acid
(BCA) Protein Assay (Pierce, Rockford, IL) and 50μg of total protein for each sample was
separated by 7.5% or 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), transferred to a polyvinylidene difluoride (PVDF) membrane, and incubated with
one or more of the following primary antibodies overnight at 4°C: phospho- JAK2, JAK2,
phospho-STAT3, STAT3 (all at 1:1000, Cell Signaling Technology Inc., MA). Membranes
were washed three times in Tris-Buffered Saline/0.1% Tween-20 (TBST), probed with
horseradish peroxidase-linked secondary antibody and visualized by enhanced
chemiluminescence (Millipore Corporation, Billerica, MA). After probing with phospho-
antibody, membranes were stripped and reprobed to determine the ratio of phospho/total
protein. All membranes were reprobed with β-actin (1:20000, Abcam, Cambridge, MA) to
ensure equal protein loading. Densitometry analysis was done on exposed films using the
software UN-SCAN-IT (ver.6.1; Silk Scientific, Orem, UT).
VEGF ELISA
Aliquots of total protein, previously quantified by BCA protein assay (Pierce, Rockford, IL),
were assayed in duplicate without dilution, using a commercially available ELISA kit, raised
against rat VEGF (R& D Systems, MN).
Statistical Analyses
Data were analyzed with SPSS software (version 14.0; Chicago, IL). Individual Student’s t-
tests were used to analyze parametric data, including avascular area/total retinal area, IVNV
area, and normalized densitometric values. For all real-time PCR, and protein analyses, an n
≥5 was used and for measurement of IVNV or areas of avascular/total retina, 14 to 20
retinas were analyzed for each group. In all experiments, at least 2 separate litters were used.
For all comparisons, p<0.05 was determined to be significant.
RESULTS
Expression of STAT3 in development and under repeated oxygen fluctuations
We first determined the expression of STAT3 at time points in room air development and
under oxygen fluctuations through post-natal day (p)14. We found only a modest increase in
expression of STAT3 mRNA under the condition of oxygen fluctuations compared to room
air at several time points (Figure 1).
AG490 reduces JAK/STAT activation under repeated oxygen fluctuations
AG490 was previously reported to inhibit the JAK/STAT pathway in adult male Sprague-
Dawley rats with streptozotocin-induced diabetes mellitus18. To test the effect of AG490 on
JAK2 and STAT3 activation, we measured the levels of each of these phosphorylated
proteins by western blot, normalized to beta actin, in pups treated with either AG490 or
control. We found that JAK2 activation was significantly reduced at p7 (p=0.03) and p14
(p=0.02) in treated compared to controls (Figure 2A,2C). Phospho/total STAT3 was also
significantly lower at p7 (p=0.033) and p14 (p=0.007) compared to controls (Figure 2B,2D).
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AG490 inhibits Intravitreous Neovascularization in Supplemental Oxygen
We then determined whether IVNV would also be reduced by inhibition of JAK2, which is
upstream from STAT3. Therefore, we treated pups in the 50/10 OIR+SO model with daily
intraperitoneal AG490 injections and measured avascular/total retinal areas, IVNV area,
phospho/total JAK2, phospho/total STAT3. At p18, IVNV was significantly reduced by
treatment with AG490 compared to control (p=0.033, Figure 3A&B). In addition, there was
a significant decrease in retinal phoshorylated JAK2 (p<0.001, Figure 4A) and
phosphorylated STAT3 (p=0.002, Figure 4B), both normalized to β-actin, in AG490 treated
animals compared to controls. An analysis of VEGF protein showed no significant
difference between the groups and there were also no significant differences in total retinal
or avascular/total retinal areas (data not shown). These data provide evidence that inhibition
of JAK/STAT signaling reduced IVNV.
JAK/STAT Signaling Triggered by Activated NADPH Oxidase from Supplemental Oxygen
Contributes to IVNV
JAK/STAT can be triggered by reactive oxygen species (ROS)21,22 and ROS are implicated
in ROP23,24,25,26. We previously reported that NADPH oxidase, which when activated
releases ROS, contributed to intravitreous neovascularization in the 50/10 OIR+SO model10.
To determine whether ROS released from activation of NADPH oxidase triggered signaling
through JAK/STAT to contribute to IVNV, pups were exposed to the ROP model (50/10
OIR+SO). All pups were treated with either control or apocynin, a specific inhibitor of
NADPH oxidase, at a dose previously shown to reduce IVNV at p18 in the 50/10 OIR+SO
model10. Whereas apocynin significantly reduced the level of phospho/total STAT3 in the
retina (p=0.04, Figure 5A), there was no difference in JAK2 phosphorylation between
apocynin-treated and untreated 50/10 OIR+SO groups (Figure 5B). These data provide
evidence that activated NADPH oxidase during supplemental oxygen triggers STAT3
signaling.
DISCUSSION
The pathogenesis of severe ROP is complex and is influenced by several variables,
including the effect of changes in oxygen concentration in developing retina and retinal
vasculature27,28; the effects of nutrients and growth factors on fragile, newly formed
capillaries29,30,31,32,33,34; and the effects of oxidative stress35,36. We are interested in the
effects of oxygen stresses, similar to those experienced by preterm infants today, on the
development of severe ROP. In contrast to the more commonly used mouse model of
extreme hyperoxia-induced capillary obliteration with subsequent relative hypoxia and
endothelial budding (which mimicked ROP in the 1940’s prior to more stringent monitoring
of oxygen), we use a model of ROP that exposes pups to fluctuations in oxygen and
supplemental oxygen, which are current risk factors for severe ROP37,38,39,7,4. In addition,
the extremes of the oxygen fluctuations used in this model cause arterial oxygen levels in
rats16 to be similar to the transcutaneous oxygen levels measured in human preterm infants
with severe ROP 4. Also, the model develops characteristics similar to severe ROP with
peripheral avascular retina16,20, followed by central vascular tortuosity40, and subsequently
intravitreous neovascularization at the junction of vascular and avascular retina41,20. Finally,
the model is highly reproducible in the measurements of characteristic features and the time
points of their development16.
We previously reported that with an increasing number of fluctuations in oxygen, there was
a trend toward an increase in oxidative compounds9. Oxidative stress can trigger signaling
of angiogenic processes through factors including VEGF, and we and others have found that
VEGF is important in the development of pathologic IVNV42,43. However, reduction of
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VEGF alone does not totally prevent IVNV42,43, and VEGF is also important in normal
development, which is ongoing in the preterm infant. Therefore, understanding of pathways
independent of or downstream of VEGF could permit the development of effective and safer
treatments.
We have reported that rescuing pups exposed to oxygen fluctuations in supplemental oxygen
(i.e., the 50/10 OIR +SO model) rather than room air, led to a reduction in retinal VEGF
levels of room air raised pups at the same post-natal day ages10. We proposed that increased
retinal vascular oxygen reduced the stimulus for VEGF overexpression within the retina.
However, we also found that retinal hypoxia, determined by conjugated pimonidazole, was
not reduced in the 50/10 OIR+SO model compared to the 50/10 OIR model (oxygen
fluctuations followed by rescue in room air)10. The overall retinal hypoxia may occur as a
result of photoreceptor metabolism which increases during development as shown by other
investigators44,45. Therefore, the activation of STAT3 in this model appears to be from
increased oxygen in the retinal vasculature; however there may also be an effect from retinal
hypoxia. In the current study, we used the same model with rescue in supplemental oxygen
(50/10 OIR+SO) to reduce the VEGF effect on IVNV in order to focus on other causative
pathways. Since JAK/STAT pathway can lead to angiogenesis through ROS, we wished to
study its role in the 50/10 OIR+SO model. We found that inhibiting JAK2 with AG490
significantly reduced IVNV with associated reduced phosphorylated JAK2 and STAT3.
Activation of NAPDH oxidase can lead to release of ROS and, in this manner, has been
reported to trigger signaling through STAT3 to increase VEGF expression in models of
diabetic retinopathy46. We previously reported that NADPH oxidase activation in the 50/10
OIR+SO model contributed to IVNV through a pathway that appeared independent of
VEGF10. In the current study, we found that activation of NADPH oxidase contributed to
IVNV through STAT3 signaling in the 50/10 OIR+SO model and that inhibiting NADPH
oxidase activation and ROS with apocynin resulted in a reduction in phosphorylated STAT3
but not phosphorylated JAK2 (Figure 6). Previous investigators have provided evidence of
direct involvement of ROS in activating STAT3 outside JAK2 activation13,14. Treatment
with apocynin10 or AG490 did not significantly affect the VEGF level in the retina,
suggesting that other angiogenic factors may be involved in IVNV. Further, since VEGF and
STAT3 have been reported to provide neuroprotection in some models47,46, distinction
among the contributions of VEGF, JAK2 and STAT3 to IVNV may provide a safer
therapeutic strategy to treat severe ROP. Additional study is needed to understand the role of
JAK/STAT signaling and pathways downstream of gp130 in OIR models and in the
developing preterm infant at risk of ROP.
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STAT3 mRNA expression measured at time points in retinas of pups from room air
development and under repeated oxygen fluctuations (rep oxy fluc) through post-natal day
(p)14. STAT3 mRNA expression was analyzed by real-time PCR in 4 to 5 retinas at each
time point and data expressed as fold change over p0. Beta-actin was run as the internal
control gene. There was only a modest increase in expression of STAT3 mRNA under the
condition of oxygen fluctuations compared to room air at several time points.
Byfield et al. Page 10














Densitometry results (A, C) and representative gel images (B, D) of phosphorylated/total
JAK2 protein (A, B) and phosphorylated/total STAT3 protein (C, D) in 50/10 OIR retinas
from AG490 treated and controls analyzed by western blot at postnatal days (p)7 and p14.
50ug total protein separated by SDS-PAGE and probed with anti- phospho JAK2 and JAK2
antibodies or anti-phospho STAT3 and STAT3 antibodies. Beta-actin was used as a loading
control and to normalize values. Odd numbered lanes are from AG490 treated retinas (p7)
and even numbered lanes show representative samples of PBS treated retinas (p7). Data
represents mean±SE of n= 5 retinas for each analysis. *p=0.04, **p=0.02, ∓p=0.03,
and ∓∓p=0.01. There were significant decreases in JAK2 and STAT3 phosphorylation
following treatment with AG490 compared to controls.
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Areas of intravitreous neovascularization (IVNV) (indicated by white arrows) at postnatal
day (p)18 in retinas from the 50/10 OIR+SO model treated with daily intraperitoneal (IP)
injections (5mg/kg) of AG490 or PBS starting at p3 and continuing through p17. (A) Mean
±SE pixel density in 10 or more retinas analyzed per group, *p=0.03 (B) Flat mount images
representative of each treatment group. AG490 treatment significantly reduced intravitreous
neovascularization in the 50/10 OIR+SO model compared to control.
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Densitometry results of JAK/STAT activation in 50/10 OIR+SO retinas from AG490 treated
and control animals analyzed by western blot at postnatal day (p)18. 50ug total protein
separated by SDS-PAGE and probed with respective antibodies. (A) anti- phospho JAK2,
and total JAK2, (B) anti-phospho STAT3, and total STAT3. Beta-actin was used as a
loading control and to normalize values. Data represents mean±SE of n= 5 retinas each
repeated from several litters. *p<0.001, and **p=0.002. Both STAT3 and JAK2 activations
were significantly reduced in retinas from AG490 treated animals compared to controls in
the 50/10 OIR+SO model.
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JAK/STAT activation in retinas from 50/10 OIR+SO model. Western blot of (A) phospho/
total STAT3 and (B) phospho/total JAK2 after treatment with daily intraperitoneal (IP)
injections of apocynin (10 mg/kg) or PBS from postnatal day (p)12 to p17 and analyzed at
p18. A total of 6 retinas were analyzed for each group and data represent values following
normalization to beta-actin. *p=0.04, n.s. – not significant. In the 50/10 OIR+SO model,
apocynin significantly reduced STAT3 but not JAK2 phosphorylaton compared to control.
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Proposed steps in signaling pathways in the 50/10 OIR+SO model that may be triggered to
cause intravitreous neonascularization.
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